• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsSeoul Pharma
    Picture of Seoul Pharma logo

    018680 — Seoul Pharma Share News

    KR₩1,8480.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      KR₩22bn
    • Enterprise Value
      KR₩20bn
    • Revenue
      KR₩52bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 018680 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    018680 Dividends
    • Brief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region

      29/11/2018 24:20
    • Brief: Seoul Pharma appoints CEO

      09/08/2018 09:05
    • Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won

      20/07/2018 08:04
    • Brief: Seoul Pharma signs contract worth 7.86 bln won

      06/11/2017 03:56
    • Brief: Seoul Pharma signs contract worth 8.62 bln won

      27/10/2017 06:20
    • Brief: Seoul Pharma signs contract worth 111.08 bln won

      22/06/2017 09:22
    • Brief: Seoul Pharma to pay annual dividend as 15 won/share for FY 2016

      15/02/2017 02:52
    • Brief: Seoul Pharma signs 3.76 bln won contract with Darou Gostar Tadbir Nikan

      09/01/2017 02:37

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.